SCIENTIFIC REPORTS. (a) NeoGenesis will keep and maintain adequate records containing laboratory data generated in the course of the Program to enable it to furnish complete and accurate information to Mitsubishi regarding the Program activities and results, including all Candidate Compound A, Candidate Compound B and NeoMorph Focused Libraries identified in the Program and all Program Intellectual Property developed by NeoGenesis during the Program. All such written records of NeoGenesis shall be open to inspection by Mitsubishi during normal business hours upon reasonable prior written notice.
(b) NeoGenesis shall provide Mitsubishi with reasonably-detailed written reports describing the results of the research performed pursuant to the Program including all Candidate Compound A, Candidate Compound B and NeoMorph Focused Libraries identified in the Program. Such reports shall be delivered to Mitsubishi at least monthly during the Program. NeoGenesis will deliver a Final Target Report (as defined in ATTACHMENT A) with respect to the Program work performed on each Target including a description of all the Candidate Compound A, Candidate Compound B and NeoMorph Sublibraries identified during the Program with respect to such Target.
SCIENTIFIC REPORTS. (a) NeoGenesis will keep and maintain adequate records containing laboratory data generated in the course of the Screening Program to enable it to furnish complete and accurate information to Immusol regarding the Screening Program activities and results, including all Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. All such written records of NeoGenesis shall be open to inspection by Immusol during normal business hours upon reasonable prior notice.
(b) NeoGenesis shall provide Immusol with reasonably-detailed written reports describing the results of the research performed pursuant to the Screening Program including all Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. Such reports shall be delivered to Immusol at least quarterly during the Screening Program. Representatives of NeoGenesis will make themselves reasonably available to discuss such reports and the progress of the Screening Program. NeoGenesis will deliver a Final Target Report (as defined in ATTACHMENT A) with respect to the Screening Program work performed on each Shared Target.
SCIENTIFIC REPORTS. (a) NeoGenesis will keep and maintain adequate records containing laboratory data generated in the course of the Screening Program to enable it to furnish complete and accurate information to Tularik regarding the Screening Program activities and results, including all Preliminary Compounds, Primary Active Compounds and NeoMorph Focused Libraries identified in the Screening Program and all Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. All such written records of NeoGenesis shall be open to inspection by Tularik during normal business hours upon reasonable prior notice.
(b) NeoGenesis shall provide Tularik with reasonably-detailed written reports describing the results of the research performed pursuant to the Screening Program including all Preliminary Compounds, Primary Active Compounds and NeoMorph Focused Libraries identified in the Screening Program and Program Intellectual Property described in clauses (a) or (b) of the Program Intellectual Property definition. Such reports shall be delivered to Tularik at least monthly during the Screening Program. Representatives of NeoGenesis will make themselves reasonably available to discuss such reports and the progress of the Screening Program. NeoGenesis will deliver a Final Target Report (as defined in ATTACHMENT A) with respect to the Screening Program work performed on each Target including a description of all the Preliminary Compounds, Primary Active Compounds and NeoMorph Focused Libraries identified during the Screening Program with respect to such Target.
SCIENTIFIC REPORTS. The Coordinator is responsible for the preparation of the annual scientific reports. The project contact persons are responsible for providing the Coordinator the reports.
SCIENTIFIC REPORTS. (a) NeoGenesis will keep and maintain adequate records containing laboratory data generated in the course of the Program to enable it to furnish complete and accurate information to CUSTOMER regarding the Program activities and results, including but not limited to all Preliminary Compounds, Primary Active Compounds and NeoMorph Focused Libraries identified or used in the Program and all NeoGenesis Program Intellectual Property developed during the Program. All such written records of NeoGenesis shall be open to inspection by CUSTOMER during normal business hours upon reasonable prior written notice.
(b) NeoGenesis shall provide CUSTOMER with reasonably-detailed written reports describing the results of the research performed pursuant to the Program including but not limited to all Preliminary Compounds, Primary Active Compounds, Selected Compounds and NeoMorph Focused Libraries identified or used in the Program. Such reports shall be delivered to CUSTOMER at least monthly during the Program. NeoGenesis will deliver a Primary Active Compounds Report with respect to the Program work performed on each Target. NeoGenesis will also deliver a Final Target Report on each Selected Compound after optimization and screening of the NeoMorph Focused Libraries.
SCIENTIFIC REPORTS. Reports to be provided: (a) Semi-annual scientific reports as of March 31st and September 30th of each year during the Term within (30) days; (b) a final scientific report within thirty (30) days after the Completion Date or upon termination of this Agreement;
SCIENTIFIC REPORTS. The Beneficiaries will submit through the Swiss Beneficiary short annual reports and a final report to SNSF on the advancement of their project, providing information about timelines and progress made in implementing the JRP. The annual reports will be checked by SNSF. The final report will be checked by the member of the evaluation panel that was responsible for the given proposal and will need to be approved by SNSF and the UEFISCDI. The report (approved) is the only document which serves as a basis for declaring the project completed.
SCIENTIFIC REPORTS. For research agreements, this report shall be used for rapidly disseminating highly significant research results or for scientific reports that are too long or that contain useful compilations of data, tables and computations not normally accepted by technical journals. It is not appropriate for a student's thesis. Before preparing a Scientific Report, obtain written permission from the Project Engineer who will then furnish detailed instructions for formatting, reproducing and distributing the report. Send the government Project Engineer two (2) copies. On its cover, a scientific report shall prominently display the following disclaimer: "The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Army or the U.S. Government."
SCIENTIFIC REPORTS. 2014, 4 (1), 1–10. DOI: 10.1038/srep05797.
SCIENTIFIC REPORTS. Each Party shall provide to the other Party as soon as practicable, written final reports summarizing the results obtained (e.g., research reports, pharmacology, toxicology, process development, technical SOPs, etc.) by such Parties in connection with the R&D Program, in the level of detail and format agreed by the Parties, which shall include at least final results, protocols, specifications, etc. For technical SOPs that embody Know-How within either Party’s Separate Technology (i.e., developed outside the R&D Program), such SOPs shall only be disclosed to the other Party as needed and treated as Know-How of the other Party pursuant to Section 5.6.2 or 5.6.3, as applicable.
